DE3485318D1 - Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen. - Google Patents

Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.

Info

Publication number
DE3485318D1
DE3485318D1 DE8484110959T DE3485318T DE3485318D1 DE 3485318 D1 DE3485318 D1 DE 3485318D1 DE 8484110959 T DE8484110959 T DE 8484110959T DE 3485318 T DE3485318 T DE 3485318T DE 3485318 D1 DE3485318 D1 DE 3485318D1
Authority
DE
Germany
Prior art keywords
sub
pharmaceutical preparations
preparations containing
hydrogen
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484110959T
Other languages
English (en)
Inventor
Barrie Dr Levitt
Morris Dr Stolar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taro Pharmaceutical Industries Ltd
Original Assignee
Taro Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taro Pharmaceutical Industries Ltd filed Critical Taro Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE3485318D1 publication Critical patent/DE3485318D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/62—Barbituric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8484110959T 1983-09-14 1984-09-13 Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen. Expired - Lifetime DE3485318D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL69722A IL69722A (en) 1983-09-14 1983-09-14 Oxopyrimidine derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DE3485318D1 true DE3485318D1 (de) 1992-01-16

Family

ID=11054532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484110959T Expired - Lifetime DE3485318D1 (de) 1983-09-14 1984-09-13 Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.

Country Status (10)

Country Link
US (1) US4628056A (de)
EP (1) EP0137343B1 (de)
JP (1) JPH0730044B2 (de)
AT (1) ATE70056T1 (de)
AU (1) AU571265B2 (de)
DE (1) DE3485318D1 (de)
DK (1) DK167615B1 (de)
IE (1) IE58038B1 (de)
IL (1) IL69722A (de)
ZA (1) ZA847274B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223037A1 (de) * 1985-10-24 1987-05-27 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Phenylbarbitursäuren und deren Herstellung
US6093820A (en) * 1997-10-02 2000-07-25 Taro Pharmaceutical Industries Ltd. Method and reagents for N-alkylating ureides
CA2306170A1 (en) * 2000-04-18 2001-10-18 Kenneth Curry Novel amino, carboxy derivatives of barbituric acid
US7683071B2 (en) * 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
AU2007200460B2 (en) * 2000-07-26 2009-10-08 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
AU2001280778B2 (en) * 2000-07-26 2004-09-02 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
US6756379B2 (en) * 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
US6939873B2 (en) * 2000-07-26 2005-09-06 Taro Pharmaceuticals Industries Limited Non-sedating barbituric acid derivatives
EP1905441A3 (de) * 2000-07-26 2008-04-23 Taro Pharmaceutical Industries Limited Nicht-sedierende Barbituratverbindungen als neuroprotektive Wirkstoffe
WO2003063872A1 (en) * 2002-01-30 2003-08-07 Taro Pharmaceutical Industries Ltd. Non-sedating barbituric acid derivatives
US6810318B2 (en) * 2002-09-13 2004-10-26 General Motors Corporation Drive torque transfer scheme
BR0317289A (pt) * 2002-12-11 2005-11-08 Taro Pharma Ind Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico
CA2572797A1 (en) 2004-07-02 2006-01-12 Daniella Gutman A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
EP1625848A1 (de) * 2004-08-10 2006-02-15 Taro Pharmaceuticals North America, Inc. Zusammensetzung und Verfahren zur verbesserten Abgabe von 5,5-Diphenylbarbitursäure
WO2008066704A2 (en) * 2006-11-14 2008-06-05 Taro Pharmaceuticals North America, Inc. Method of improving bioavailability for non-sedating barbiturates
EP2755945A1 (de) * 2011-09-12 2014-07-23 Council of Scientific & Industrial Research Arylierte beta-dicarbonylverbindungen und verfahren zu ihrer herstellung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1960170A (en) * 1934-05-22 Cc - phenylethyl - n -
US3930006A (en) * 1963-04-30 1975-12-30 Aspro Nicholas Ltd Antiparkinsonism compositions and method
US4046894A (en) * 1968-08-05 1977-09-06 Bristol-Myers Company Certain barbituric acid derivatives used as anticonvulsant agents
US3919427A (en) * 1972-06-02 1975-11-11 Kendall & Co Therapeutic compositions containing 1-methyl-3-alkoxymethyl-5,5-disubstituted barbituric acid compounds
US3948896A (en) * 1973-02-28 1976-04-06 The Kendall Company N-mono(alkoxymethyl) phenobarbitals, process therefor and therapeutic composition and method containing same

Also Published As

Publication number Publication date
IE58038B1 (en) 1993-06-16
ATE70056T1 (de) 1991-12-15
JPH0730044B2 (ja) 1995-04-05
DK431784D0 (da) 1984-09-11
JPS6084272A (ja) 1985-05-13
IL69722A0 (en) 1983-12-30
AU3287584A (en) 1985-03-21
EP0137343B1 (de) 1991-12-04
EP0137343A2 (de) 1985-04-17
US4628056A (en) 1986-12-09
AU571265B2 (en) 1988-04-14
EP0137343A3 (en) 1986-06-11
DK431784A (da) 1985-03-15
IL69722A (en) 1986-09-30
DK167615B1 (da) 1993-11-29
IE842332L (en) 1985-03-14
ZA847274B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
ATE70056T1 (de) Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.
IL78175A0 (en) Azolylmethyloxiranes,their preparation and their use as crop protection agents
TR200001603T2 (tr) Yeni bileşikler
DE69523951D1 (de) Stabilisierung der prostaglandinzusammensetzungen
GR3022966T3 (en) Fluoro substituted benzocycloheptapyridine compounds, compositions and methods of use as antihistaminic compounds
IL81002A0 (en) Pyrazoline derivatives,processes for their preparation and pesticidal compositions containing the same
NO904595L (no) Fremgangsmaate for potensiering av den analgetiske effekt av curcuminoider.
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
ES2001106A6 (es) Procedimiento para la obtencion de 1-aril-pirazoles
DE69928646D1 (de) Derivate des streptogramins, ihre herstellung und sie enthaltende zubereitungen
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
DK415789D0 (da) Tetracykliske antidepressive midler
DE69330601D1 (de) Serotoninergische ergolin derivate
GR3032950T3 (en) Substituted fused and bridged bicyclic compounds as therapeutic agents
ES8604520A1 (es) Procedimiento para preparar derivados de 2(1h)-piridona
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
IL73757A0 (en) Thiolane-2,4-dione-3-carboxamides,their preparation and their use as pesticides
ES2122034T3 (es) Difosfatos de catecolaminas y composiciones farmaceuticas que los contienen.
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
DK151082A (da) Fungicidt middel indeholdende triazolylderivater
IT8421331A0 (it) Composizioni e procedimento per la stabilizzazione di antralina.
NZ212585A (en) Aroyl-substituted thiazines and pharmaceutical compositions
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
MX9300890A (es) Nuevos pirazolilpirazoles substituidos, su elaboracion asi como productos intermedios para su elaboracion y, su empleo como agentes con efecto herbicida.
AP9300577A0 (en) Cyanophenyl-pyrazolines.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER 2. PATENTINHABER LAUTET RICHTIG: TARO VIT INDUSTRIES LTD., HAIFA BAY, IL

8364 No opposition during term of opposition